AMYLYX PHARMACEUTICALS, INC.
AMLXLoading price...
Profit/Loss
| PARTICULARS | TTM | 2025 | 2024 | 2023 | 2022 | 2022 |
|---|---|---|---|---|---|---|
| Operating Revenue | 0.00 | 0.00 | 87.37M | 380.79M | 22.23M | 345.00k |
| Cost of Revenue | 0.00 | 124.63M | 25.44M | 2.99M | ||
| Gross Profit | 0.00 | -37.26M | 355.35M | 19.24M | ||
| Operating Expenses | 162.10M | 153.29M | 218.41M | 316.54M | 220.58M | 185.24M |
| Profit after Tax (Net Income) | -152.09M | -144.74M | -301.74M | 49.27M | -198.38M | -184.01M |